Quartuccio, Luca
 Distribuzione geografica
Continente #
AS - Asia 107
EU - Europa 88
NA - Nord America 49
SA - Sud America 4
AF - Africa 2
Totale 250
Nazione #
US - Stati Uniti d'America 48
SG - Singapore 43
FI - Finlandia 24
DE - Germania 22
IT - Italia 22
HK - Hong Kong 20
TR - Turchia 20
CN - Cina 17
PL - Polonia 6
IE - Irlanda 4
PK - Pakistan 4
BR - Brasile 3
CZ - Repubblica Ceca 3
EG - Egitto 2
GB - Regno Unito 2
PH - Filippine 2
AT - Austria 1
CH - Svizzera 1
ES - Italia 1
MX - Messico 1
PE - Perù 1
PT - Portogallo 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 250
Città #
Singapore 33
Helsinki 21
Hong Kong 20
Istanbul 20
Munich 11
Romola 11
Beijing 10
New York 6
Warsaw 6
Shanghai 5
Ashburn 4
Dublin 4
Faisalabad 4
Brno 3
Curitiba 3
Lappeenranta 3
Milan 3
Cairo 2
Falkenstein 2
Quezon City 2
Coimbra 1
Ganzhou 1
Jeddah 1
Kilburn 1
Madrid 1
Moscow 1
Naples 1
Petriolo 1
Santa Clara 1
Vienna 1
Zurich 1
Totale 184
Nome #
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys 29
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 24
COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis 22
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 20
COVAD survey 2 long-term outcomes: unmet need and protocol 17
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 17
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 16
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 15
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group 13
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 12
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 12
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 11
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 9
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 8
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys 7
Breakthrough SARS‑CoV‑2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID‑19 Vaccination in Autoimmune Disease (COVAD) study 7
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 7
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 7
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 7
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment 5
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment 5
Totale 270
Categoria #
all - tutte 3.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 13 0 1 2 0 3 5
2023/2024133 3 5 11 12 2 14 4 1 29 3 5 44
2024/2025113 7 20 17 45 24 0 0 0 0 0 0 0
Totale 270